Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance

Abstract

The context-dependent reciprocal interaction between the cancer cells and surrounding fibroblasts is imperative for regulating malignant potential, metabolic reprogramming, immunosuppression, and ECM deposition. However, recent evidence also suggests that cancer-associated fibroblasts induce chemoresistance in cancer cells to various anticancer regimens. Because of the protumorigenic function of cancer-associated fibroblasts, these stromal cell types have emerged as fascinating therapeutic targets for cancer. However, this notion was recently challenged by studies that targeted cancer-associated fibroblasts and highlighted the underlying heterogeneity by identifying a subset of these cells with tumor-restricting functions. Hence, it is imperative to understand the heterogeneity and heterotypic signaling of cancer-associated fibroblasts to target tumor-promoting signaling processes by sparing tumor-restricting ones. In this review, we discuss the heterogeneity and heterotypic signaling of cancer-associated fibroblasts in shaping drug resistance and also list the cancer-associated fibroblast-targeting therapeutics.

Keywords

Tumor microenvironment / CAFs / heterogeneity / ECM / metabolic reprogramming / heterotypic signaling / drug resistance / natural products

References

[1] Polyak K.Breast cancer: origins and evolution.J Clin Invest2007;117:3155-63 PMCID:PMC2045618

[2] Bremnes RM,Al-Saad S.The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer.J Thorac Oncol2011;6:209-17

[3] Kalluri R.The biology and function of fibroblasts in cancer.Nat Rev Cancer2016;16:582-98

[4] Butti R,Nimma R,Kundu IG.Osteopontin signaling in shaping tumor microenvironment conducive to malignant progression. In: Birbrair A, editor. Tumor Microenvironment. Cham: Springer International Publishing; 2021. pp. 419-41.

[5] Strieter R,Phan S.Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells.Biochem Biophys Res Commun1989;162:694-700

[6] Rollins BJ,Ernst T.The human homolog of the JE gene encodes a monocyte secretory protein.Mol Cell Biol1989;9:4687-95 PMCID:PMC363615

[7] Kuzet SE.Fibroblast activation in cancer: when seed fertilizes soil.Cell Tissue Res2016;365:607-19

[8] Butti R,Kundu G.Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression.Oncogene2021;40:2002-17

[9] Karagiannis GS,Erdman SE,Riddell RH.Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue.Mol Cancer Res2012;10:1403-18 PMCID:PMC4399759

[10] Monteran L.The Dark Side of Fibroblasts: Cancer-associated fibroblasts as mediators of immunosuppression in the tumor microenvironment.Front Immunol2019;10:1835 PMCID:PMC6688105

[11] Wu F,Liu J.Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.Signal Transduct Target Ther2021;6:218 PMCID:PMC8190181

[12] Özdemir BC,Carstens JL.Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.Cancer Cell2015;28:831-3

[13] Rhim AD,Thomas DH.Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.Cancer Cell2014;25:735-47 PMCID:PMC4096698

[14] Lee JJ,Wang H.Stromal response to Hedgehog signaling restrains pancreatic cancer progression.Proc Natl Acad Sci USA2014;111:E3091-100 PMCID:PMC4121834

[15] Kalluri R.The basics of epithelial-mesenchymal transition.J Clin Invest2009;119:1420-8 PMCID:PMC2689101

[16] Molenaar JC.[From the library of the Netherlands journal of medicine. Rudolf virchow: die cellularpathologie in ihrer begrundung auf physiologische und pathologische gewebelehre; 1858].Ned Tijdschr Geneeskd2003;147:2236-44

[17] Kalluri R.Fibroblasts in cancer.Nat Rev Cancer2006;6:392-401

[18] Cirri P.Cancer associated fibroblasts: the dark side of the coin.Am J Cancer Res2011;1:482-97 PMCID:PMC3186047

[19] Calvo F,Grande-Garcia A.Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts.Nat Cell Biol2013;15:637-46 PMCID:PMC3836234

[20] Micallef L,Billet F,Darby IA.The myofibroblast, multiple origins for major roles in normal and pathological tissue repair.Fibrogenesis Tissue Repair2012;5:S5 PMCID:PMC3368789

[21] Desmoulière A,Gabbiani G.Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis.Lab Invest2003;83:1689-707

[22] Darby IA,Bonté F.Fibroblasts and myofibroblasts in wound healing.Clin Cosmet Investig Dermatol2014;7:301-11 PMCID:PMC4226391

[23] Tomasek JJ,Hinz B,Brown RA.Myofibroblasts and mechano-regulation of connective tissue remodelling.Nat Rev Mol Cell Biol2002;3:349-63

[24] Hamburg-Shields E,Mullin NK,Atit RP.Sustained β-catenin activity in dermal fibroblasts promotes fibrosis by up-regulating expression of extracellular matrix protein-coding genes.J Pathol2015;235:686-97 PMCID:PMC4357547

[25] Rock JR,Cronce MJ.Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition.Proc Natl Acad Sci USA2011;108:E1475-83 PMCID:PMC3248478

[26] LeBleu VS,O'Connell J.Origin and function of myofibroblasts in kidney fibrosis.Nat Med2013;19:1047-53 PMCID:PMC4067127

[27] Erez N,Olson P,Hanahan D.Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an nf-kappab-dependent manner.Cancer Cell2010;17:135-47

[28] Li Q,Wang Y.MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation.Sci Rep2013;3:2038 PMCID:PMC3687228

[29] Goulet C, Bernard G, Tremblay S, Chabaud S, Bolduc S, Pouliot F. Exosomes induce fibroblast differentiation into cancer-associated fibroblasts through TGFβ signaling.Mol Cancer Res2018;16:1196-204

[30] Lee KW,Sung CO.Twist1 is a key regulator of cancer-associated fibroblasts.Cancer Res2015;75:73-85

[31] Gaggioli C,Hidalgo-Carcedo C.Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells.Nat Cell Biol2007;9:1392-400

[32] Nurmik M,Rodriguez F,Letellier E.In search of definitions: cancer-associated fibroblasts and their markers.Int J Cancer2020;146:895-905 PMCID:PMC6972582

[33] Butti R,Gunasekaran VP,Kumar D.Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges.Mol Cancer2018;17:34 PMCID:PMC5817867

[34] Nissen NI,Willumsen N.Collagens and cancer associated fibroblasts in the reactive stroma and its relation to cancer biology.J Exp Clin Cancer Res2019;38:115 PMCID:PMC6404286

[35] Pazolli E,Brehm S.Senescent stromal-derived osteopontin promotes preneoplastic cell growth.Cancer Res2009;69:1230-9 PMCID:PMC2633422

[36] Butti R GP,Venkata RNN,Kundu GC.Role of osteopontin in tumor microenvironment: a new paradigm in cancer therapy. in: multi-targeted approach to treatment of cancer. Adis, Cham; 2015. pp. 113–25.

[37] Radisky DC,Littlepage LE.Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability.Nature2005;436:123-7 PMCID:PMC2784913

[38] Tuhkanen H,Kosma VM.Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p.Int J Cancer2004;109:247-52

[39] Kurose K,Matsumoto S,Zhou XP.Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas.Nat Genet2002;32:355-7

[40] Moinfar F,Arnould L,Ratschek M.Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis.Cancer Res2000;60:2562-6

[41] Radisky DC,Bissell MJ.Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT?.J Cell Biochem2007;101:830-9 PMCID:PMC2838476

[42] Medici D,Olsen BR.Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3.Mol Biol Cell2008;19:4875-87 PMCID:PMC2575183

[43] Zeisberg EM,Xie L,Kalluri R.Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts.Cancer Res2007;67:10123-8

[44] Akatsu Y,Yoshimatsu Y.Fibroblast growth factor signals regulate transforming growth factor-β-induced endothelial-to-myofibroblast transition of tumor endothelial cells via Elk1.Mol Oncol2019;13:1706-24 PMCID:PMC6670013

[45] Hosaka K,Seki T.Pericyte-fibroblast transition promotes tumor growth and metastasis.Proc Natl Acad Sci USA2016;113:E5618-27 PMCID:PMC5035870

[46] Hung SC,Yang WK.Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging.Clin Cancer Res2005;11:7749-56

[47] Kidd S,Dembinski JL.Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging.Stem Cells2009;27:2614-23 PMCID:PMC4160730

[48] Hall B,Marini F.The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. In: Kauser K, Zeiher A, editors. Bone Marrow-Derived Progenitors. Berlin: Springer Berlin Heidelberg; 2007. pp. 263-83.

[49] Dwyer RM,Harrington KA.Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.Clin Cancer Res2007;13:5020-7

[50] Spaeth E,Dembinski J,Marini F.Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells.Gene Ther2008;15:730-8

[51] Feng B.Review of mesenchymal stem cells and tumors: executioner or coconspirator?.Cancer Biother Radiopharm2009;24:717-21

[52] Spaeth EL,Sasser AK.Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression.PLoS One2009;4:e4992 PMCID:PMC2661372

[53] Weber CE,Wai PY.Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer.Oncogene2015;34:4821-33 PMCID:PMC4476970

[54] Kojima Y,Eaton EN.Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts.Proc Natl Acad Sci USA2010;107:20009-14 PMCID:PMC2993333

[55] Procopio MG,Al Labban D.Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation.Nat Cell Biol2015;17:1193-204

[56] Shimoda M,Jackson HW.Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state.Nat Cell Biol2014;16:889-901

[57] Li Z,Zhou J.Nodal facilitates differentiation of fibroblasts to cancer-associated fibroblasts that support tumor growth in melanoma and colorectal cancer.Cells2019;8:538 PMCID:PMC6627322

[58] Calon A,Batlle E.TGF-beta in CAF-mediated tumor growth and metastasis.Semin Cancer Biol2014;25:15-22

[59] Avgustinova A,Robertson D.Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness.Nat Commun2016;7:10305 PMCID:PMC4735631

[60] Albrengues J,Grasset E.Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts.Nat Commun2015;6:10204 PMCID:PMC4682161

[61] Costa A,Scholer-Dahirel A.Fibroblast heterogeneity and immunosuppressive environment in human breast cancer.Cancer Cell2018;33:463-479.e10

[62] Bonneau C,Kieffer Y.A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.Breast Cancer Res2020;22:76 PMCID:PMC7362513

[63] Li H,Sengupta D.Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors.Nat Genet2017;49:708-18

[64] Pelon F,Kieffer Y.Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms.Nat Commun2020;11:404 PMCID:PMC6972713

[65] Givel AM,Scholer-Dahirel A.miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers.Nat Commun2018;9:1056 PMCID:PMC5849633

[66] Lambrechts D,Boeckx B.Phenotype molding of stromal cells in the lung tumor microenvironment.Nat Med2018;24:1277-89

[67] Puram SV,Parikh AS.Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer.Cell2017;171:1611-1624.e24 PMCID:PMC5878932

[68] Kieffer Y,Gentric G.Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer.Cancer Discov2020;10:1330-51

[69] Biffi G,Spielman B.IL1-induced JAK/STAT signaling is antagonized by TGFβ to shape CAF heterogeneity in pancreatic ductal adenocarcinoma.Cancer Discov2019;9:282-301 PMCID:PMC6368881

[70] Öhlund D,Biffi G.Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer.J Exp Med2017;214:579-96 PMCID:PMC5339682

[71] Elyada E,Laise P.Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts.Cancer Discov2019;9:1102-23 PMCID:PMC6727976

[72] Hosein AN,Wang Z.Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution.JCI Insight2019;5:129212 PMCID:PMC6777805

[73] Bernard V,Huang J.Single-cell transcriptomics of pancreatic cancer precursors demonstrates epithelial and microenvironmental heterogeneity as an early event in neoplastic progression.Clin Cancer Res2019;25:2194-205 PMCID:PMC6445737

[74] Dominguez CX,Keerthivasan S.Single-cell RNA sequencing reveals stromal evolution into LRRC15(+) myofibroblasts as a determinant of patient response to cancer immunotherapy.Cancer Discov2020;10:232-53

[75] Friedman G,David E.Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4(+) and PDPN(+) CAFs to clinical outcome.Nat Cancer2020;1:692-708

[76] Sebastian A,Martin KA.Single-cell transcriptomic analysis of tumor-derived fibroblasts and normal tissue-resident fibroblasts reveals fibroblast heterogeneity in breast cancer.Cancers2020;12:1307 PMCID:PMC7281266

[77] Kerdidani D,Verrou K.Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts.J Exp Med2022;219:e20210815 PMCID:PMC8764966

[78] Bartoschek M,Bocci M.Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing.Nat Commun2018;9:5150 PMCID:PMC6279758

[79] Cremasco V,Grauel AL.FAP delineates heterogeneous and functionally divergent stromal cells in immune-excluded breast tumors.Cancer Immunol Res2018;6:1472-85 PMCID:PMC6597261

[80] Quante M,Tomita H.Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth.Cancer Cell2011;19:257-72 PMCID:PMC3060401

[81] Zhou B,Li N.Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways.Int J Oncol2016;48:2087-97

[82] Zhang D,Li Y.Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells.Sci Rep2017;7:16231 PMCID:PMC5701200

[83] Li J,Long X,Xiang X.Mir-1-mediated paracrine effect of cancer-associated fibroblasts on lung cancer cell proliferation and chemoresistance.Oncol Rep2016;35:3523-31

[84] Yi Y,Wang Z.Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling.Biochim Biophys Acta Mol Basis Dis2018;1864:793-803

[85] Stanisavljevic J,Herrera M.Snail1-expressing fibroblasts in the tumor microenvironment display mechanical properties that support metastasis.Cancer Res2015;75:284-95

[86] Blanco-Gómez A,Corchado-Cobos R.Stromal SNAI2 is required for ERBB2 breast cancer progression.Cancer Res2020;80:5216-30 PMCID:PMC7718390

[87] Wang L,Cui JY,Chen YT.CAFs enhance paclitaxel resistance by inducing EMT through the IL-6/JAK2/STAT3 pathway.Oncol Rep2018;39:2081-90 PMCID:PMC5928760

[88] Wei L,Li G.Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer.Cell Death Dis2018;9:1065

[89] Li Z,Qi Y.Participation of CCL1 in snail-positive fibroblasts in colorectal cancer contribute to 5-fluorouracil/paclitaxel chemoresistance.Cancer Res Treat2018;50:894-907 PMCID:PMC6056976

[90] Leung CS,Yip KP.Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.J Clin Invest2018;128:589-606 PMCID:PMC5785271

[91] Zhai J,Xie G.Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer.Cancer Lett2019;454:37-43

[92] Uchihara T,Yonemura A.Extracellular vesicles from cancer-associated fibroblasts containing annexin A6 induces FAK-YAP activation by stabilizing β1 integrin, enhancing drug resistance.Cancer Res2020;80:3222-35

[93] Wei L,Lu Y.Cancer-associated fibroblasts-mediated ATF4 expression promotes malignancy and gemcitabine resistance in pancreatic cancer via the TGF-β1/SMAD2/3 pathway and ABCC1 transactivation.Cell Death Dis2021;12:334 PMCID:PMC8007632

[94] Chandra Jena B,Banerjee I.Paracrine TGF-β1 from breast cancer contributes to chemoresistance in cancer associated fibroblasts via upregulation of the p44/42 MAPK signaling pathway.Biochem Pharmacol2021;186:114474

[95] Zhang F,Gao HF.Cancer-associated fibroblasts induce epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer via CXCL12/CXCR4 axis.Future Oncol2020;16:2619-33

[96] Martelli AM,Chappell W.Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.Leukemia2011;25:1064-79

[97] Qin X,Wang X.Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5.Genome Biol2019;20:12 PMCID:PMC6332863

[98] Wang H,Wang L.Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer.Aging (Albany NY)2021;13:14456-68 PMCID:PMC8202839

[99] Zhang HW,Liu JB.Cancer-associated fibroblast-derived exosomal microRNA-24-3p enhances colon cancer cell resistance to MTX by down-regulating CDX2/HEPH axis.J Cell Mol Med2021;25:3699-713

[100] Deng X,Zhang X.Long noncoding RNA CCAL transferred from fibroblasts by exosomes promotes chemoresistance of colorectal cancer cells.Int J Cancer2020;146:1700-16

[101] Zhao Q,Qin G.Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma.Cancer Lett2021;518:35-48

[102] Shan G,Gu J.Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN.Cell Oncol2021;44:45-59

[103] Liu L,Luo H.GPR30-mediated HMGB1 upregulation in CAFs induces autophagy and tamoxifen resistance in ERα-positive breast cancer cells.Aging (Albany NY)2021;13:16178-97 PMCID:PMC8266353

[104] Butti R,Kumar TVS,Kundu GC.Breast cancer stem cells: biology and therapeutic implications.Int J Biochem Cell Biol2019;107:38-52

[105] Vermeulen L,van der Heijden M.Wnt activity defines colon cancer stem cells and is regulated by the microenvironment.Nat Cell Biol2010;12:468-76

[106] Lotti F,Pai RK.Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A.J Exp Med2013;210:2851-72 PMCID:PMC3865474

[107] Hu Y,Mu L.Fibroblast-derived exosomes contribute to chemoresistance through priming cancer stem cells in colorectal cancer.PLoS One2015;10:e0125625 PMCID:PMC4418721

[108] Hu YB,Mu L.Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance.Oncogene2019;38:1951-65

[109] Sansone P,Rajasekhar VK.Evolution of cancer stem-like cells in endocrine-resistant metastatic breast cancers is mediated by stromal microvesicles.Cancer Res2017;77:1927-41

[110] Valenti G,Heynen GJJE.Cancer stem cells regulate cancer-associated fibroblasts via activation of hedgehog signaling in mammary gland tumors.Cancer Res2017;77:2134-47

[111] Cazet AS,Elsworth BL.Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer.Nat Commun2018;9:2897 PMCID:PMC6057940

[112] Tang YA,Bao Y.Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer.Proc Natl Acad Sci USA2018;115:E5990-9 PMCID:PMC6042102

[113] Su S,Yao H.CD10(+)GPR77(+) cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness.Cell2018;172:841-856.e16

[114] Ren J,Zhang D.Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.Theranostics2018;8:3932-48 PMCID:PMC6071523

[115] Du Y,Moller M,Tse YT.Intracellular notch1 signaling in cancer-associated fibroblasts dictates the plasticity and stemness of melanoma stem/initiating cells.Stem Cells2019;37:865-75 PMCID:PMC6986496

[116] Phi LTH,Yang YG.Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment.Stem Cells Int2018;2018:5416923 PMCID:PMC5850899

[117] Maeda M,Iida N.Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3.Gut2020;69:243-51

[118] Sung PJ,Imbach J.Cancer-associated fibroblasts produce netrin-1 to control cancer cell plasticity.Cancer Res2019;79:3651-61

[119] Bu L,Yasuda T,Ishimoto T.Functional diversity of cancer-associated fibroblasts in modulating drug resistance.Cancer Sci2020;111:3468-77 PMCID:PMC7541012

[120] Xing F,Watabe K.Cancer associated fibroblasts (CAFs) in tumor microenvironment.Front Biosci2010;15:166-79 PMCID:PMC2905156

[121] Zhao H,Baddour J.Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism.Elife2016;5:e10250 PMCID:PMC4841778

[122] Zhang W,Yu A.GFPT2-Expressing cancer-associated fibroblasts mediate metabolic reprogramming in human lung adenocarcinoma.Cancer Res2018;78:3445-57 PMCID:PMC6030462

[123] Mishra R,Placencio V.Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming.J Clin Invest2018;128:4472-84 PMCID:PMC6159981

[124] Suzuki A,Leland P.Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer.PLoS One2019;14:e0217131 PMCID:PMC6532891

[125] Wilde L,Domingo-Vidal M.Metabolic coupling and the Reverse Warburg Effect in cancer: implications for novel biomarker and anticancer agent development.Semin Oncol2017;44:198-203 PMCID:PMC5737780

[126] Yu T,Hou Y.Cytoplasmic GPER translocation in cancer-associated fibroblasts mediates cAMP/PKA/CREB/glycolytic axis to confer tumor cells with multidrug resistance.Oncogene2017;36:2131-45

[127] Yoshida GJ.Metabolic reprogramming: the emerging concept and associated therapeutic strategies.J Exp Clin Cancer Res2015;34:111 PMCID:PMC4595070

[128] Apicella M,Fiore S.Increased lactate secretion by cancer cells sustains non-cell-autonomous adaptive resistance to MET and EGFR targeted therapies.Cell Metab2018;28:848-865.e6

[129] Vukovic V.Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan.Br J Cancer1997;75:1167-72

[130] Kugeratski FG,Neilson LJ.Hypoxic cancer-associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling.Sci Signal2019;12 PMCID:PMC6794160

[131] Ziani L,Chouaib S.Hypoxia increases melanoma-associated fibroblasts immunosuppressive potential and inhibitory effect on T cell-mediated cytotoxicity.Oncoimmunology2021;10:1950953 PMCID:PMC8312612

[132] Masamune A,Watanabe T,Hirota M.Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer.Am J Physiol Gastrointest Liver Physiol2008;295:G709-17

[133] Guido C,Capparelli C.Metabolic reprogramming of cancer-associated fibroblasts by TGF-beta drives tumor growth: connecting TGF-beta signaling with “Warburg-like” cancer metabolism and L-lactate production.Cell Cycle2012;11:3019-35

[134] Bartrons R,Rodríguez-García A.Fructose 2, 6-bisphosphate in cancer cell metabolism.Front Oncol2018;8:331 PMCID:PMC6131595

[135] Martinez-Outschoorn UE,Lin Z.Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.Cell Cycle2010;9:3515-33 PMCID:PMC3047617

[136] Zhu Y,Qiao C.Targeting PFKFB3 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitor.Oncogene2018;37:2837-49

[137] Semenza GL.Signal transduction to hypoxia-inducible factor 1.Biochemical Pharmacology2002;64:993-8

[138] Hu Y,Huang H.Recent agents targeting HIF-1α for cancer therapy.J Cell Biochem2013;114:498-509

[139] Pranzini E,Paoli P,Taddei ML.Metabolic reprogramming in anticancer drug resistance: a focus on amino acids.Trends Cancer2021;7:682-99

[140] Bacci M,Smiriglia A.Fat and furious: lipid metabolism in antitumoral therapy response and resistance.Trends Cancer2021;7:198-213

[141] Li Z,Qin Z.Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming.Theranostics2021;11:8322-36 PMCID:PMC8343997

[142] Lee U,Jho EH.Regulation of Hippo signaling by metabolic pathways in cancer.Biochim Biophys Acta Mol Cell Res2022;1869:119201

[143] Ishii G,Neri S.Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment.Adv Drug Deliv Rev2016;99:186-96

[144] Navab R,To C.Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer.Oncogene2016;35:1899-908 PMCID:PMC4833874

[145] Li X,Yu X,Huang G.Reverse of microtubule-directed chemotherapeutic drugs resistance induced by cancer-associated fibroblasts in breast cancer.Onco Targets Ther2019;12:7963-73 PMCID:PMC6773970

[146] Quail DF.Microenvironmental regulation of tumor progression and metastasis.Nat Med2013;19:1423-37 PMCID:PMC3954707

[147] Joyce MH,James ER.Phenotypic basis for matrix stiffness-dependent chemoresistance of breast cancer cells to doxorubicin.Front Oncol2018;8:337 PMCID:PMC6134055

[148] Hao J,Pintilie M.Characterization of distinct populations of carcinoma-associated fibroblasts from non-small cell lung carcinoma reveals a role for ST8SIA2 in cancer cell invasion.Neoplasia2019;21:482-93 PMCID:PMC6458340

[149] Chen Y,Yang S.Type I collagen deletion in αSMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer.Cancer Cell2021;39:548-565.e6 PMCID:PMC8423173

[150] Soysal SD,Muenst SE.Role of the tumor microenvironment in breast cancer.Pathobiology2015;82:142-52

[151] Gonzalez-Avila G,Mendoza-Posada DA,Garcia-Hernandez AA.Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer.Crit Rev Oncol Hematol2019;137:57-83

[152] Glentis A,Mariani P.Cancer-associated fibroblasts induce metalloprotease-independent cancer cell invasion of the basement membrane.Nat Commun2017;8:924

[153] Pontiggia O,Raffo D.The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin.Breast Cancer Res Treat2012;133:459-71 PMCID:PMC3719875

[154] Folgueira MA,Katayama ML.Markers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: a systematic review including our case series.Biosci Rep2013;33 PMCID:PMC3860578

[155] Yoshida T,Goto K.Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation.Clin Cancer Res2015;21:642-51

[156] Ibrahim N',Mohamed IN.Wound healing properties of selected natural products.Int J Environ Res Public Health2018;15:2360 PMCID:PMC6266783

[157] Porwal A,Bhagwat G.Polyherbal formulation Anoac-H suppresses the expression of RANTES and VEGF for the management of bleeding hemorrhoids and fistula.Mol Med Rep2021;24:736 PMCID:PMC8404094

[158] Santana FP,Mernak MI.Evidences of herbal medicine-derived natural products effects in inflammatory lung diseases.Mediators Inflamm2016;2016:2348968 PMCID:PMC4942669

[159] Cragg GM.Natural products: a continuing source of novel drug leads.Biochim Biophys Acta2013;1830:3670-95 PMCID:PMC3672862

[160] McLarty J,Smith M,Ankem M.Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro.Cancer Prev Res2009;2:673-82

[161] Gray AL,Bigelow RL,Cardelli JA.The polyphenols (-)-epigallocatechin-3-gallate and luteolin synergistically inhibit TGF-β-induced myofibroblast phenotypes through RhoA and ERK inhibition.PLoS One2014;9:e109208 PMCID:PMC4182889

[162] Sun Y,Higano C.Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B.Nat Med2012;18:1359-68 PMCID:PMC3677971

[163] Hu K,Goodwin TJ,Liu Q.Quercetin remodels the tumor microenvironment to improve the permeation, retention, and antitumor effects of nanoparticles.ACS Nano2017;11:4916-25 PMCID:PMC5961944

[164] Wilken R,Wang MB.Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.Mol Cancer2011;10:12 PMCID:PMC3055228

[165] Hendrayani SF,Aboussekhra A.Curcumin triggers p16-dependent senescence in active breast cancer-associated fibroblasts and suppresses their paracrine procarcinogenic effects.Neoplasia2013;15:631-40 PMCID:PMC3664995

[166] Wang Q,Xie F et al.Curcumin suppresses epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells by inhibiting cancer-associated fibroblasts.Am J Cancer Res2017;7:125-33 PMCID:PMC5250686

[167] Xing Y,Wang Z.Fraxinellone has anticancer activity in vivo by inhibiting programmed cell death-ligand 1 expression by reducing hypoxia-inducible factor-1α and STAT3.Pharmacol Res2018;135:166-80

[168] Wu X,Ma Y.CUG-binding protein 1 regulates HSC activation and liver fibrogenesis.Nat Commun2016;7:13498 PMCID:PMC5118555

[169] Pei Y,Huang Y.Sequential targeting TGF-β signaling and KRAS mutation increases therapeutic efficacy in pancreatic cancer.Small2019;15:e1900631

[170] Abate M,Masullo M.Mangostanin, a xanthone derived from garcinia mangostana fruit, exerts protective and reparative effects on oxidative damage in human keratinocytes.Pharmaceuticals2022;15:84 PMCID:PMC8780152

[171] Zhang KJ,Yang K,Wang JX.Anticarcinogenic effects of α-mangostin: a review.Planta Med2017;83:188-202

[172] Feng J,Wang J.Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer.Biomaterials2020;241:119907

[173] Chen JK.I only have eye for ewe: the discovery of cyclopamine and development of Hedgehog pathway-targeting drugs.Nat Prod Rep2016;33:595-601 PMCID:PMC4856577

[174] Zhang B,Shen S.Cyclopamine disrupts tumor extracellular matrix and improves the distribution and efficacy of nanotherapeutics in pancreatic cancer.Biomaterials2016;103:12-21

[175] Zhao J,Abbruzzese J,Li C.Cyclopamine-loaded core-cross-linked polymeric micelles enhance radiation response in pancreatic cancer and pancreatic stellate cells.Mol Pharm2015;12:2093-100 PMCID:PMC5055750

[176] Kasala ER,Madana RM,Gogoi R.Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives.Toxicol Lett2015;233:214-25

[177] Lin YM,Hsiang YP.Chrysin Attenuates cell viability of human colorectal cancer cells through autophagy induction unlike 5-fluorouracil/oxaliplatin.Int J Mol Sci2018;19:1763 PMCID:PMC6032318

[178] Chen L,Jiang Z.Chrysin induced cell apoptosis through H19/let-7a/COPB2 axis in gastric cancer cells and inhibited tumor growth.Front Oncol2021;11:651644 PMCID:PMC8209501

[179] Wen Q,Zhou J.8-bromo-7-methoxychrysin suppress stemness of SMMC-7721 cells induced by co-culture of liver cancer stem-like cells with hepatic stellate cells.BMC Cancer2019;19:224 PMCID:PMC6416872

[180] Chen S,Morine Y.Epigallocatechin-3-gallate hinders metabolic coupling to suppress colorectal cancer malignancy through targeting aerobic glycolysis in cancer associated fibroblasts.Int J Oncol2022;60:19 PMCID:PMC8776327

[181] Yamanaka T,Yokobori T.Conophylline inhibits hepatocellular carcinoma by inhibiting activated cancer-associated fibroblasts through suppression of G protein-coupled receptor 68.Mol Cancer Ther2021;20:1019-28

[182] Wang Z,Wang C.Triptonide inhibits the pathological functions of gastric cancer-associated fibroblasts.Biomed Pharmacother2017;96:757-67

[183] Wang ZF,Wang L.Paeoniflorin inhibits migration- and invasion-promoting capacities of gastric cancer associated fibroblasts.Chin J Integr Med2019;25:837-44

[184] Thongchot S,Vidoni C.Erratum to “resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells” [Cancer Letters 430C (2018) 160-171].Cancer Lett2018;434:206-7

[185] Dauer P,Gupta VK.Inactivation of cancer-associated-fibroblasts disrupts oncogenic signaling in pancreatic cancer cells and promotes its regression.Cancer Res2018;78:1321-33 PMCID:PMC5935584

[186] Zhao J,Hsiao CH.Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy.Biomaterials2018;159:215-28 PMCID:PMC6203960

[187] Dong R,Zhang Z,Hua Y.Polyphyllin I inhibits gastric cancer cell proliferation by downregulating the expression of fibroblast activation protein alpha (FAP) and hepatocyte growth factor (HGF) in cancer-associated fibroblasts.Biochem Biophys Res Commun2018;497:1129-34

[188] Wang ZF,Zhu Z.Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts.World J Gastroenterol2017;23:8512-25 PMCID:PMC5752711

[189] Cao X.Ursolic acid inhibits proliferation, migration and invasion of human papillary thyroid carcinoma cells via CXCL12/CXCR4/CXCR7 axis through cancer-associated fibroblasts.Hum Exp Toxicol2022;41:9603271221111333

[190] Guo J,Shi X.A CFH peptide-decorated liposomal oxymatrine inactivates cancer-associated fibroblasts of hepatocellular carcinoma through epithelial-mesenchymal transition reversion.J Nanobiotechnology2022;20:114 PMCID:PMC8898522

[191] Yamanaka T,Yokobori T.Nintedanib inhibits intrahepatic cholangiocarcinoma aggressiveness via suppression of cytokines extracted from activated cancer-associated fibroblasts.Br J Cancer2020;122:986-94 PMCID:PMC7109053

[192] Lee HM,Yeo SY.Drug repurposing screening identifies bortezomib and panobinostat as drugs targeting cancer associated fibroblasts (CAFs) by synergistic induction of apoptosis.Invest New Drugs2018;36:545-60

[193] ClinicalTrials.gov. A study to evaluate the clinical efficacy of JNJ-42756493 (Erdafitinib), a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in asian participants with advanced non-small-cell lung cancer, urothelial cancer, esophageal cancer or cholangiocarcinoma. Available from: https://ClinicalTrials.gov/show/NCT02699606 [Last accessed on 2 Feb 2023]

[194] ClinicalTrials.gov. Plerixafor and cemiplimab in metastatic pancreatic cancer. Available from: https://ClinicalTrials.gov/show/NCT04177810 [Last accessed on 2 Feb 2023]

[195] ClinicalTrials.gov. Second-line study of PEGPH20 and pembro for HA high metastatic PDAC. Available from: https://ClinicalTrials.gov/show/NCT03634332 [Last accessed on 2 Feb 2023]

[196] ClinicalTrials.gov. Phase I study of AT13148, a novel AGC kinase inhibitor. Available from: https://ClinicalTrials.gov/show/NCT01585701 [Last accessed on 2 Feb 2023]

[197] ClinicalTrials.gov. FOLFIRINOX plus IPI-926 for advanced pancreatic adenocarcinoma. Available from: https://ClinicalTrials.gov/show/NCT01383538 [Last accessed on 2 Feb 2023]

[198] Sahai E,Cukierman E.A framework for advancing our understanding of cancer-associated fibroblasts.Nat Rev Cancer2020;20:174-86 PMCID:PMC7046529

[199] Murphy JE,Ryan DP.Total neoadjuvant therapy with FOLFIRINOX in combination with losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: a phase 2 clinical trial.JAMA Oncol2019;5:1020-7 PMCID:PMC6547247

[200] Shimizu T,Takeda M.A first-in-Asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors.Cancer Chemother Pharmacol2016;77:997-1003 PMCID:PMC4844649

[201] ClinicalTrials.gov. Paricalcitol plus gemcitabine and nab-paclitaxel in metastatic pancreatic cancer. Available from: https://ClinicalTrials.gov/show/NCT03520790 [Last accessed on 2 Feb 2023]

[202] ClinicalTrials.gov. A study in metastatic cancer and advanced or metastatic unresectable pancreatic cancer. Available from: https://ClinicalTrials.gov/show/NCT01373164 [Last accessed on 2 Feb 2023]

[203] ClinicalTrials.gov. A study of galunisertib (LY2157299) and durvalumab (MEDI4736) in participants with metastatic pancreatic cancer. Available from: https://ClinicalTrials.gov/show/NCT02734160 [Last accessed on 2 Feb 2023]

[204] ClinicalTrials.gov. A study evaluating IPI-926 in combination with gemcitabine in patients with metastatic pancreatic cancer. Available from: https://ClinicalTrials.gov/show/NCT01130142 [Last accessed on 2 Feb 2023]

[205] ClinicalTrials.gov. Vismodegib and gemcitabine hydrochloride in treating patients with advanced pancreatic cancer. Available from: https://ClinicalTrials.gov/show/NCT01195415 [Last accessed on 2 Feb 2023]